for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up
Healthcare

BRIEF-KalVista Pharmaceuticals reports Q1 loss per share of $0.51

Sept 14 (Reuters) - Kalvista Pharmaceuticals Inc

* KalVista pharmaceuticals reports fiscal first quarter results

* Q1 loss per share $0.51

* Q1 revenue $100,000 versus $1.0 million

* KalVista Pharmaceuticals Inc - Intravitreal Diabetic Macular Edema Candidate KVD001 remains on track for Phase 2 in 2017

* KalVista Pharmaceuticals Inc - cash and cash equivalents were $26.5 million as of July 31, 2017 Source text for Eikon: Further company coverage:

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up